What was recalled
This page synthesizes the hydrolyzed protein veterinary diet framework for food allergy and adverse food reaction management. Canine food allergy and cutaneous adverse food reaction typically present with chronic itch, secondary skin infection, otitis externa, perianal pruritus, and gastrointestinal signs. Diagnosis requires an elimination diet trial using a novel protein source (rabbit, venison, kangaroo) or a hydrolyzed protein source, fed exclusively for 8-12 weeks with clinical response monitoring, followed by challenge feeding to confirm. Hydrolyzed protein diets are the preferred elimination diet format for veterinary nutritionists because they reduce both the protein-specific allergy risk AND the contamination risk from previously-fed proteins.
The enzymatic hydrolysis process uses food-grade enzymes (typically pepsin, trypsin, or proteinase mixtures) to cleave parent protein into smaller peptides. The molecular weight distribution of the hydrolyzed protein is the key validation parameter. Different products use different parent proteins and different hydrolysis processes: Hill’s z/d uses hydrolyzed chicken liver; Royal Canin Hydrolyzed Protein uses hydrolyzed soy or hydrolyzed feather protein; Purina HA uses hydrolyzed soy protein isolate; Blue Buffalo HF uses hydrolyzed chicken. The target molecular weight distribution for veterinary therapeutic diets is typically below 12,000 Daltons for 95%+ of the protein content, with most peptides below 5,000 Daltons. The 10,000-15,000 Dalton threshold for immune recognition is supported by canine food allergy research but has individual-pet variability — some allergic dogs react to peptides smaller than 10,000 Daltons.
Why it was recalled
The structural limitations include: (1) incomplete hydrolysis — some commercial hydrolyzed diets have measurable intact protein content or large-peptide content (above 15,000 Daltons) that can trigger reactions in highly sensitive dogs; (2) cross-reactivity — dogs allergic to chicken may cross-react with hydrolyzed chicken because the hydrolyzed peptides share epitopes with intact chicken protein, even when individual peptides are below the molecular weight threshold; (3) parent protein selection — some hydrolyzed diets use parent proteins (soy, feather, fish) with their own allergen potential in cross-reactive patients; (4) contamination during manufacturing — shared production lines and supply chains can introduce intact parent protein from previously-fed sources, defeating the elimination diet protocol; (5) palatability — hydrolyzed protein typically has bitter taste from the small peptide content; some dogs refuse to eat hydrolyzed diets despite the therapeutic indication.
The American College of Veterinary Internal Medicine (ACVIM) and World Small Animal Veterinary Association (WSAVA) consensus positions on food allergy management support hydrolyzed protein diets as one of two validated elimination diet options (the other being novel protein). The choice between hydrolyzed and novel protein depends on individual pet history, protein source availability, and pet preference. The diagnostic protocol requires strict exclusivity — no treats, table scraps, flavored medications, or alternative protein sources for the 8-12 week trial period — for the elimination diet to support diagnosis.
Health risks for your pet
The documented limitations of hydrolyzed protein veterinary diets do not produce direct acute health risks but can produce diagnostic and management failures: (1) diagnostic failure — approximately 10-20% of food-allergic dogs do not respond to hydrolyzed diets; the elimination trial fails to identify food allergy as the underlying cause; (2) management failure — long-term feeding of hydrolyzed diet may produce gradual return of allergic symptoms in initially-responsive dogs due to incomplete hydrolysis, cross-reactivity, or new allergen development; (3) palatability-driven undernutrition — some dogs refuse to eat hydrolyzed diets despite the therapeutic indication; weight loss and inadequate nutrition can result. For most food-allergic dogs, hydrolyzed protein veterinary diets produce reliable clinical improvement and support long-term management; the limitations affect a minority of cases.
What to do if you bought affected product
Pet owners managing food allergies in dogs or cats can navigate the hydrolyzed protein veterinary diet framework through: (1) veterinary diagnostic protocol — work with a veterinarian or veterinary dermatologist on the elimination diet trial design; strict 8-12 week exclusivity is essential; (2) product selection — veterinary therapeutic hydrolyzed diets are typically only available through veterinarian or veterinary pharmacy; over-the-counter hydrolyzed claims may not meet the therapeutic threshold; (3) palatability backup — discuss alternative formulations (Hill’s z/d, Royal Canin HP, Purina HA, Blue HF) if the initial selection is not palatable to the pet; (4) elimination trial completion — partial protocol completion produces ambiguous diagnostic outcome; commit to the full 8-12 week trial or do not start; (5) challenge feeding for diagnosis confirmation — successful elimination diet response should be confirmed by re-introduction of the suspect food allergen to verify food allergy is the underlying cause vs. spontaneous clinical improvement; (6) long-term management — pets with confirmed food allergy benefit from continued hydrolyzed protein veterinary diet OR novel protein diet feeding with veterinary nutritionist consultation. The food allergy elimination diet controversy covers the broader diagnostic protocol framework.
How this affects KibbleIQ’s grade
KibbleIQ methodology v15 covers commercial dry kibble per our published methodology; veterinary therapeutic prescription diets including hydrolyzed protein formulations are scored on the standard retail-product rubric without dual-lens medical-efficacy weighting. Future methodology v2 will introduce explicit medical-efficacy scoring for veterinary therapeutic diets, recognizing that the ingredient deck composition (e.g., soy protein isolate, feather protein, hydrolyzed by-products) reflects therapeutic design rather than retail-product quality positioning. Pet owners working with veterinary nutritionists on food allergy management should not select hydrolyzed therapeutic diets based on the retail-product rubric grade alone — the therapeutic indication is the primary selection driver.